Related references
Note: Only part of the references are listed.Therapeutic considerations for Mdm2: not just a one trick pony
Jason A. Lehman et al.
EXPERT OPINION ON DRUG DISCOVERY (2008)
MDMX promotes proteasomal turnover of p2l at G1 and early S phases independently of, but in cooperation with, MDM2
Yetao Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The RING finger domain of MDM2 is essential for MDM2-mediated TGF-β resistance
Christian Kannemeier et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1α and Hdm2
Gretchen A. LaRusch et al.
CANCER RESEARCH (2007)
Mornings with art, lessons learned: Feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses
Erik A. Bey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cells
Mark W. Jackson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
ARF-BP1/mule is a critical mediator of the ARF tumor suppressor
DL Chen et al.
CELL (2005)
Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor
T Criswell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma
A Slack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation
CH Uchida et al.
EMBO JOURNAL (2005)
Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1α expression
JI Bárdos et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Overexpression of transforming growth factor β1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation
SL Lu et al.
CANCER RESEARCH (2004)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
The ubiquitin ligase COP1 is a critical negative regulator of p53
D Dornan et al.
NATURE (2004)
Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2
MY Li et al.
SCIENCE (2003)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein
T Criswell et al.
CANCER BIOLOGY & THERAPY (2003)
Links between tumor suppressors:: p53 is required for TGF-β gene responses by cooperating with Smads
M Cordenonsi et al.
CELL (2003)
Direct interactions between HIF-1α and Mdm2 modulate p53 function
DL Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Polyubiquitination of p53 by a ubiquitin ligase activity of p300
SR Grossman et al.
SCIENCE (2003)
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
RP Leng et al.
CELL (2003)
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line
L Xie et al.
BREAST CANCER RESEARCH (2003)
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration
AV Bakin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Opposing effects of Ras on p53:: Transcriptional activation of mdm2 and induction of p19ARF
S Ries et al.
CELL (2000)
The MDM2 RING-finger domain is required to promote p53 nuclear export
RK Geyer et al.
NATURE CELL BIOLOGY (2000)
The loss of mdm2 induces p53 mediated apoptosis
S de Rozieres et al.
ONCOGENE (2000)
A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland
C Schulze-Garg et al.
ONCOGENE (2000)
Share Paper
